C-Pulse efficacy mechanism largely understood and demonstrated.
LVADs mechanism of efficacy another problem.
Know how to make stem cells, no how to milk the market but don't know how to get them to work.
Gene therapy obvious targets found unsuccessful.
The trial is now to confirm C-Pulse's efficacy rather than to prove it.
Huge differerance.
Finally the end of cheap shares.
goldman sachs now own 2% of Sunshine Heart, page-3
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)